# Lidocaine Hydrochloride

NDC: 63739-170
Generic name: Lidocaine Hydrochloride
Labeler / Manufacturer: McKesson Corporation dba SKY Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220622
Marketing ended: 20261119
FDA application: ANDA212821

## Active ingredients

- LIDOCAINE HYDROCHLORIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63739-170"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63739-170
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1eabd6b-9bb8-646f-e053-2a95a90a7b83